Literature DB >> 27478177

Classification Models for Predicting Cytochrome P450 Enzyme-Substrate Selectivity.

Tao Zhang1,2, Hao Dai1, Limin Angela Liu3, David F V Lewis4, Dongqing Wei5.   

Abstract

Cytochrome P450 (CYP) is an important drug-metabolizing enzyme family. Different CYPs often have different substrate preferences. In addition, one drug molecule may be preferentially metabolized by one or more CYP enzymes. Therefore, the classification and prediction of substrate specificity of CYP enzymes are of importance to the understanding of drug metabolisms and may help guide the development of new drugs. In this study, we used three different machine learning methods to classify CYP substrates for predicting CYP-substrate specificity based solely on structural and physicochemical properties of the substrates. We first built a simple decision tree model to classify substrates of four CYP enzymes, 1A2, 2C9, 2D6 and 3A4 with more than 78 % classification accuracy. We then built a single-label eight-class model and a multilabel five-class model to classify substrates of eight CYP enzymes and to classify substrates that can be metabolized by more than one CYP enzymes, respectively. Above 90 % and >80 % prediction accuracy was achieved for the single-label and multilabel models, respectively. The main improvement of our models over existing ones is the automated and unbiased selection of descriptors by genetic algorithms, which makes our methods applicable for larger data sets and increased number of CYP enzymes.
Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Bioinformatics; Decision tree; Enzymes; Genetic algorithm; Neural network

Year:  2012        PMID: 27478177     DOI: 10.1002/minf.201100052

Source DB:  PubMed          Journal:  Mol Inform        ISSN: 1868-1743            Impact factor:   3.353


  6 in total

1.  Predicting CYP2C19 catalytic parameters for enantioselective oxidations using artificial neural networks and a chirality code.

Authors:  Jessica H Hartman; Steven D Cothren; Sun-Ha Park; Chul-Ho Yun; Jerry A Darsey; Grover P Miller
Journal:  Bioorg Med Chem       Date:  2013-04-22       Impact factor: 3.641

2.  Computational explanation for bioactivation mechanism of targeted anticancer agents mediated by cytochrome P450s: A case of Erlotinib.

Authors:  Chun-Zhi Ai; Yong Liu; Wei Li; De-Meng Chen; Xin-Xing Zhu; Ya-Wei Yan; Du-Chu Chen; Yi-Zhou Jiang
Journal:  PLoS One       Date:  2017-06-19       Impact factor: 3.240

3.  The FDA-Approved Drug Cobicistat Synergizes with Remdesivir To Inhibit SARS-CoV-2 Replication In Vitro and Decreases Viral Titers and Disease Progression in Syrian Hamsters.

Authors:  Andrea Savarino; Marina Lusic; Iart Luca Shytaj; Mohamed Fares; Lara Gallucci; Bojana Lucic; Mahmoud M Tolba; Liv Zimmermann; Julia M Adler; Na Xing; Judith Bushe; Achim D Gruber; Ina Ambiel; Ahmed Taha Ayoub; Mirko Cortese; Christopher J Neufeldt; Bettina Stolp; Mohamed Hossam Sobhy; Moustafa Fathy; Min Zhao; Vibor Laketa; Ricardo Sobhie Diaz; Richard E Sutton; Petr Chlanda; Steeve Boulant; Ralf Bartenschlager; Megan L Stanifer; Oliver T Fackler; Jakob Trimpert
Journal:  mBio       Date:  2022-03-01       Impact factor: 7.786

4.  Modelling species selectivity in rat and human cytochrome P450 2D enzymes.

Authors:  Grace H C Edmund; David F V Lewis; Brendan J Howlin
Journal:  PLoS One       Date:  2013-05-14       Impact factor: 3.240

Review 5.  Predicting mammalian metabolism and toxicity of pesticides in silico.

Authors:  Robert D Clark
Journal:  Pest Manag Sci       Date:  2018-05-15       Impact factor: 4.845

6.  Enhancing reaction-based de novo design using a multi-label reaction class recommender.

Authors:  Gian Marco Ghiandoni; Michael J Bodkin; Beining Chen; Dimitar Hristozov; James E A Wallace; James Webster; Valerie J Gillet
Journal:  J Comput Aided Mol Des       Date:  2020-02-28       Impact factor: 3.686

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.